Jin, Xin, Rui Sun, Zhu Li, Xianwu Wang, Xia Xiong, Wenyi Lu, Hairong Lyu, Xia Xiao, Yunpeng Tian, Hongkai Zhang, Zhihong Fang, Luqiao Wang, and Mingfeng Zhao. 2020. “CD22-Targeted Glyco-Engineered Natural Killer Cells Offer a Further Treatment Option for B-Cell Acute Lymphoblastic Leukemia”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2023.284241.